NCT03416530 2025-02-14ONC201 in Pediatric H3 K27M GliomasJazz PharmaceuticalsPhase 1 Terminated134 enrolled 1 FDA
NCT01121588 2025-01-23Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK)PfizerPhase 1 Terminated44 enrolled 22 charts 1 FDA